A new immuno-oncology target – SUMOylation
Author:
Funder
National Institutes of Health
Pancreatic Cancer Action Network
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference15 articles.
1. Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing;Decque;Nat. Immunol.,2016
2. SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response;Crowl;Proc. Natl. Acad. Sci. U. S. A.,2018
3. A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models;Lightcap;Sci. Transl. Med.,2021
4. Mechanism of SUMOylation-mediated regulation of type I IFN expression;Du;J. Mol. Biol.,2023
5. The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation;Nakamura;Blood,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. STAT3 interactome predicts presence of proteins that regulate immune system in oral squamous cell carcinoma;Journal of Oral Biosciences;2024-09
2. Dysregulated gene expression of SUMO machinery components induces the resistance to anti-PD-1 immunotherapy in lung cancer by upregulating the death of peripheral blood lymphocytes;Frontiers in Immunology;2024-08-15
3. Expression of SUMO and NF-κB genes in hepatitis B virus-associated hepatocellular carcinoma patients: An observational study;Medicine;2024-06-28
4. Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma;Journal of Nanobiotechnology;2024-06-18
5. UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma;Frontiers in Bioscience-Landmark;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3